What is the APAC Project in the Japan Pharmaceutical Manufacturers Association (JPMA)?
The APAC Project is an organization established by the Japan Pharmaceutical Manufacturers Association for the purpose of promoting APAC activities, such as planning and organizing APAC Conferences, the APAC Convention and the APAC Steering Committee.
The 14th APAC group photo
APAC Mission
APAC has been tackling various issues under the theme of "Access to Innovative Medicines (ATIM)" in order to realize its mission "to rapidly deliver innovative medicines to the people of Asia.
APAC is tackling its priorities one step at a time while contributing to the health of the people of Asia.
Since its establishment in 2012, APAC has provided a unique opportunity for regulators, academia, and industry to engage in constructive discussions on timely topics to improve "Access to Innovative Medicines" (ATIM) in Asia.
The APAC Working Groups and Task Forces on Drug Discovery Alliance (DA), Regulation and Approval (RA), and Manufacturing, Quality Control and Supply (MQS) are active and have achieved a high level of success in their efforts to promote country collaboration and regulatory harmonization.
Furthermore, in response to technological innovations and changes in the environment, we have begun to address each of these issues from an industry perspective by launching new thematic teams on "e-labeling" in 2020 and "Asia Universal Health Coverage (aUHC)" in 2021.
APAC Project Management Structure in the Pharmaceutical Cooperative Association of Japan
APAC Value Chain and Activity Areas
APAC has established the APAC Expert Working Group (EWG) and Task Forces (TF) to manage and implement various activities.
